180 related articles for article (PubMed ID: 19487603)
1. Can we override clopidogrel resistance?
Pena A; Collet JP; Hulot JS; Silvain J; Barthélémy O; Beygui F; Funck-Brentano C; Montalescot G
Circulation; 2009 Jun; 119(21):2854-7. PubMed ID: 19487603
[No Abstract] [Full Text] [Related]
2. Bedside evaluation of thienopyridine antiplatelet therapy.
Price MJ
Circulation; 2009 May; 119(19):2625-32. PubMed ID: 19451364
[No Abstract] [Full Text] [Related]
3. Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.
Mega JL; Close SL; Wiviott SD; Shen L; Hockett RD; Brandt JT; Walker JR; Antman EM; Macias WL; Braunwald E; Sabatine MS
Circulation; 2009 May; 119(19):2553-60. PubMed ID: 19414633
[TBL] [Abstract][Full Text] [Related]
4. CYP2C19 genotype-guided antiplatelet therapy in a patient with clopidogrel resistance.
Rai M; Seip RL; Gupta A; McKay RG; Hirst J; Thompson PD; Ruaño G
Conn Med; 2012 May; 76(5):267-72. PubMed ID: 22685981
[TBL] [Abstract][Full Text] [Related]
5. [Technological and biopharmaceutical aspects. Antiplatelet agents for oral administration].
Breitkreutz J
Pharm Unserer Zeit; 2009; 38(4):330-7. PubMed ID: 19572353
[No Abstract] [Full Text] [Related]
6. Optimizing platelet inhibition in clopidogrel poor metabolizers: therapeutic options and practical considerations.
Angiolillo DJ; Ueno M
JACC Cardiovasc Interv; 2011 Apr; 4(4):411-4. PubMed ID: 21511220
[No Abstract] [Full Text] [Related]
7. Population pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in aspirin-treated patients with stable coronary artery disease.
Ernest CS; Small DS; Rohatagi S; Salazar DE; Wallentin L; Winters KJ; Wrishko RE
J Pharmacokinet Pharmacodyn; 2008 Dec; 35(6):593-618. PubMed ID: 19023649
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
Matetzky S; Shenkman B; Guetta V; Shechter M; Beinart R; Goldenberg I; Novikov I; Pres H; Savion N; Varon D; Hod H
Circulation; 2004 Jun; 109(25):3171-5. PubMed ID: 15184279
[TBL] [Abstract][Full Text] [Related]
9. Response to antiplatelet treatment: from genes to outcome.
Giusti B; Abbate R
Lancet; 2010 Oct; 376(9749):1278-81. PubMed ID: 20801497
[No Abstract] [Full Text] [Related]
10. The year in interventional cardiology.
Dixon SR; Grines CL; O'Neill WW
J Am Coll Cardiol; 2010 May; 55(20):2272-86. PubMed ID: 20466207
[No Abstract] [Full Text] [Related]
11. Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease.
Varenhorst C; James S; Erlinge D; Brandt JT; Braun OO; Man M; Siegbahn A; Walker J; Wallentin L; Winters KJ; Close SL
Eur Heart J; 2009 Jul; 30(14):1744-52. PubMed ID: 19429918
[TBL] [Abstract][Full Text] [Related]
12. Prasugrel offers consistent platelet control in appropriate patients requiring treatment.
Aalbers J
Cardiovasc J Afr; 2011; 22(2):107, 109. PubMed ID: 21556460
[No Abstract] [Full Text] [Related]
13. Platelet inhibitors: update on clopidogrel (Plavix) and the recently approved prasugrel (Effient).
Wynn RL
Gen Dent; 2010; 58(1):7-9. PubMed ID: 20129886
[No Abstract] [Full Text] [Related]
14. Is prasugrel more effective than clopidogrel at preventing future cardiac events?
Lange CG
JAAPA; 2011 Feb; 24(2):52, 55. PubMed ID: 21387971
[No Abstract] [Full Text] [Related]
15. Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel.
Motovska Z; Widimsky P
Vasc Health Risk Manag; 2009; 5(1):475-81. PubMed ID: 19475783
[TBL] [Abstract][Full Text] [Related]
16. Prasugrel.
Tantry US; Bliden KP; Gurbel PA
Expert Opin Investig Drugs; 2006 Dec; 15(12):1627-33. PubMed ID: 17107286
[TBL] [Abstract][Full Text] [Related]
17. Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study.
Angiolillo DJ; Saucedo JF; Deraad R; Frelinger AL; Gurbel PA; Costigan TM; Jakubowski JA; Ojeh CK; Effron MB;
J Am Coll Cardiol; 2010 Sep; 56(13):1017-23. PubMed ID: 20846599
[TBL] [Abstract][Full Text] [Related]
18. [Interaction of statins with clopidogrel].
Von Scheidt W
Internist (Berl); 2004 Mar; 45(3):363-5. PubMed ID: 14997315
[No Abstract] [Full Text] [Related]
19. Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans.
Farid NA; Kurihara A; Wrighton SA
J Clin Pharmacol; 2010 Feb; 50(2):126-42. PubMed ID: 19948947
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel Resistance: case reports of CYP2C19 gene variants in suspected coronary stent thrombosis.
Dick RJ; Dear AE; Byron KA
Heart Lung Circ; 2011 Oct; 20(10):657-8. PubMed ID: 21215696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
